Study of polymethylmethacrylate/tricalcium silicate composite cement for orthopedic application
Biomedical Journal · 2023-06 · 46 (3) · 100540
DOI: 10.1016/j.bj.2022.05.005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Journal, 2023-06. Verfasst von Yang Wei und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Engineering and Biotechnology, National Taipei University of Technology (Taipei Tech), Taipei, Taiwan. Hauptthemen laut MEDLINE: Polymethyl Methacrylate, Bone Cements. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Taiwan, National Taipei University of Technology.
Abstract (Originalsprache)
BACKGROUND: Among orthopedic surgery materials, poly (methyl methacrylate) (PMMA) is most commonly used for its excellent mechanical properties and rapid self-setting time. However, PMMA bone cement has been reported to cause thermal necrosis and to have poor bioactivity, which must be improved. In contrast, tricalcium silicate (TCS), the most significant component of Portland Cement and the most effective bone cement material, might not always meet the needs of the cement due to its poor mechanical properties and elevated pH levels during hydration. We hypothesize that the benefits of both PMMA and TCS can be harnessed by mixing them together in different proportions. This would represent a better solution for the issues faced when using them alone. METHODS: We, therefore, prepared a novel organic-inorganic PMMA/TCS composite bone cement mixing PMMA and different amounts of TCS and tested its effect on the biophysical properties. RESULTS: The addition of 30% TCS reduced the exothermic temperature and pH variation during cement setting and hydration processes. However, the mechanical and handling properties of the bioactive PMMA/TCS composite were not affected. The in vitro study also revealed that the composite materials had higher cell viability than pure PMMA and TCS. Also, the in vivo study on animals indicated that the composite materials were more capable of forming bone, which further reinforced the biocompatibility of the proposed PMMA/TCS bone cement. CONCLUSION: By combining the advantages of each component, it could be possible to construct a more effective composite bone cement material. This would meet the needs of implantation material for orthopedic surgeries or a possible bone filler.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Engineering and Biotechnology, National Taipei University of Technology (Taipei Tech), Taipei, Taiwan.
- Department of Stomatology, MacKay Memorial Hospital, Taipei, Taiwan.
- Department of Materials, University of Oxford, Oxford, United Kingdom.
- Department of Chemical Engineering and Biotechnology, National Taipei University of Technology (Taipei Tech), Taipei, Taiwan. Electronic address: rjchung@ntut.edu.tw.
Förderung
- Ministry of Science and Technology, Taiwan
- National Taipei University of Technology
Zitieren
APA
Wei, Y., Baskaran, N., Wang, H. Y., Su, Y. C., Nabilla, S. C., & Chung, R. J. (2023). Study of polymethylmethacrylate/tricalcium silicate composite cement for orthopedic application. Biomedical Journal, 46(3), 100540. https://doi.org/10.1016/j.bj.2022.05.005
Vancouver
Wei Y, Baskaran N, Wang HY, Su YC, Nabilla SC, Chung RJ. Study of polymethylmethacrylate/tricalcium silicate composite cement for orthopedic application. Biomedical Journal. 2023;46(3):100540. doi:10.1016/j.bj.2022.05.005
BibTeX
@article{Wei2023,
author = {Wei, Yang and Baskaran, Nareshkumar and Wang, Huey-Yuan and Su, Yu-Chieh and Nabilla, Sasza Chyntara and Chung, Ren-Jei},
title = {Study of polymethylmethacrylate/tricalcium silicate composite cement for orthopedic application},
journal = {Biomedical Journal},
year = {2023},
volume = {46},
number = {3},
pages = {100540},
doi = {10.1016/j.bj.2022.05.005}
}
EUVIMED